SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2 )*

 

 

AVEO PHARMACEUTICALS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

053588109

(CUSIP Number)

December 31, 2013

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)

 

  ¨ Rule 13d-1(c)

 

  x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

MPM BioVentures II, L.P.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

102,222

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

102,222

   8.   

Shared Dispositive Power

 

0

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

102,222

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

0.2%

12.  

Type of Reporting Person (See Instructions)

 

PN

 

Page 2 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

MPM BioVentures II-QP, L.P.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

927,554

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

927,554

   8.   

Shared Dispositive Power

 

0

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

927,554

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

1.8%

12.  

Type of Reporting Person (See Instructions)

 

PN

 

Page 3 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Germany

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

326,563

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

326,563

   8.   

Shared Dispositive Power

 

0

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

326,563

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

0.6%

12.  

Type of Reporting Person (See Instructions)

 

PN

 

Page 4 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

MPM Asset Management Investors 2002 BVII LLC

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

15,779

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

15,779

   8.   

Shared Dispositive Power

 

0

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

15,779

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

0.0%

12.  

Type of Reporting Person (See Instructions)

 

OO

 

Page 5 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

MPM Asset Management II, L.P.

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

1,356,339*

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

1,356,339*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,356,339*

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

2.6%

12.  

Type of Reporting Person (See Instructions)

 

PN

 

* The shares are held as follows: 927,554 by MPM BioVentures II-QP, L.P. (“BV II QP”); 102,222 by MPM BioVentures II, L.P. (“BV II”); and 326,563 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG (“BV KG”). The Reporting Person is the direct general partner of BV II QP, BV II and BV KG.

 

Page 6 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

MPM Asset Management II LLC

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

1,356,339*

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

1,356,339*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,356,339*

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

2.6%

12.  

Type of Reporting Person (See Instructions)

 

OO

 

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; and 326,563 by BV KG. The Reporting Person is the indirect general partner of BV II QP, BV II and BV KG.

 

Page 7 of 20


CUSIP No. 053588109

 

  1   

Name of Reporting Persons

 

Ansbert Gadicke

  2  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3  

SEC USE ONLY

 

  4  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

     

Sole Voting Power

 

0

   6   

Shared Voting Power

 

1,372,118*

   7   

Sole Dispositive Power

 

0

   8   

Shared Dispositive Power

 

1,372,118*

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,372,118*

10  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11  

Percent of Class Represented by Amount in Row (9)

 

2.7%

12  

Type of Reporting Person (See Instructions)

 

IN

 

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by MPM Asset Management Investors 2002 BVII LLC (“AM 2002”); and 326,563 by BV KG. MPM Asset Management II, L.P. (“AM LP”) and MPM Asset Management II LLC (“AM II LLC”) are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

 

Page 8 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

Luke Evnin

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

1,372,118*

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

1,372,118*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,372,118*

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

2.7%

12.  

Type of Reporting Person (See Instructions)

 

IN

 

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

 

Page 9 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

Nicholas Galakatos

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

1,372,118*

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

1,372,118*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,372,118*

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

2.7%

12.  

Type of Reporting Person (See Instructions)

 

IN

 

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

 

Page 10 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

Michael Steinmetz

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

1,372,118*

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

1,372,118*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,372,118*

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

2.7%

12.  

Type of Reporting Person (See Instructions)

 

IN

 

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

 

Page 11 of 20


CUSIP No. 053588109

 

  1.   

Name of Reporting Persons

 

Kurt Wheeler

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

 

(a)  ¨        (b)  x

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

   5.    

Sole Voting Power

 

0

   6.   

Shared Voting Power

 

1,372,118*

   7.   

Sole Dispositive Power

 

0

   8.   

Shared Dispositive Power

 

1,372,118*

  9.  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

1,372,118*

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

2.7%

12.  

Type of Reporting Person (See Instructions)

 

IN

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

 

Page 12 of 20


Item 1.

 

  (a) Name of Issuer

AVEO Pharmaceuticals, Inc.

 

  (b) Address of Issuer’s Principal Executive Offices

650 E. Kendall Street

Cambridge, MA 02142

Item 2.

 

  (a) Name of Person Filing

MPM BioVentures II, LP

MPM BioVentures II-QP, L.P.

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

MPM Asset Management Investors 2002 BVII LLC

MPM Asset Management II, L.P.

MPM Asset Management II LLC

Ansbert Gadicke

Luke Evnin

Nicholas Galakatos

Michael Steinmetz

Kurt Wheeler

 

  (b) Address of Principal Business Office or, if none, Residence

c/o MPM Capital LLC

The John Hancock Tower

200 Clarendon Street, 54th Floor

Boston, MA 02116

 

  (c) Citizenship

All entities were organized in Delaware except MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG, which was organized in Germany. The individuals are all United States citizens.

 

  (d) Title of Class of Securities

Common Stock

 

  (e) CUSIP Number

053588109

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

 

Page 13 of 20


Item 4. Ownership

 

  (a) Amount Beneficially Owned:

 

MPM BioVentures II, L.P.

     102,222   

MPM BioVentures II-QP, L.P.

     927,554   

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

     326,563   

MPM Asset Management Investors 2002 BVII LLC

     15,779   

MPM Asset Management II, L.P.

     1,356,339 (1) 

MPM Asset Management II LLC

     1,356,339 (1) 

Ansbert Gadicke

     1,372,118 (2) 

Luke B. Evnin

     1,372,118 (2) 

Nicholas Galakatos

     1,372,118 (2) 

Michael Steinmetz

     1,372,118 (2) 

Kurt Wheeler

     1,372,118 (2) 

Percent of Class:

 

MPM BioVentures II, L.P.

     0.2

MPM BioVentures II-QP, L.P.

     1.8.

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

     0.6

MPM Asset Management Investors 2002 BVII LLC

     0.0

MPM Asset Management II, L.P.

     2.6

MPM Asset Management II LLC

     2.6

Ansbert Gadicke

     2.7

Luke B. Evnin

     2.7

Nicholas Galakatos

     2.7

Michael Steinmetz

     2.7

Kurt Wheeler

     2.7

 

  (b) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote

 

MPM BioVentures II, L.P.

     102,222   

MPM BioVentures II-QP, L.P.

     927,554   

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

     326,563   

MPM Asset Management Investors 2002 BVII LLC

     15,779   

MPM Asset Management II, L.P.

     0   

MPM Asset Management II LLC

     0   

Ansbert Gadicke

     0   

Luke B. Evnin

     0   

Nicholas Galakatos

     0   

Michael Steinmetz

     0   

Kurt Wheeler

     0   

 

Page 14 of 20


  (ii) Shared power to vote or to direct the vote

 

MPM BioVentures II, L.P.

     0   

MPM BioVentures II-QP, L.P.

     0   

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

     0   

MPM Asset Management Investors 2002 BVII LLC

     0   

MPM Asset Management II, L.P.

     1,356,339 (1) 

MPM Asset Management II LLC

     1,356,339 (1) 

Ansbert Gadicke

     1,372,118 (2) 

Luke B. Evnin

     1,372,118 (2) 

Nicholas Galakatos

     1,372,118 (2) 

Michael Steinmetz

     1,372,118 (2) 

Kurt Wheeler

     1,372,118 (2) 

 

  (iii) Sole power to dispose or to direct the disposition of

 

MPM BioVentures II, LP

     102,222   

MPM BioVentures II-QP, L.P.

     927,554   

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

     326,563   

MPM Asset Management Investors 2002 LLC

     15,779   

MPM Asset Management II, L.P.

     0   

MPM Asset Management II LLC

     0   

Ansbert Gadicke

     0   

Luke Evnin

     0   

Nicholas Galakatos

     0   

Michael Steinmetz

     0   

Kurt Wheeler

     0   

 

  (iv) Shared power to dispose or to direct the disposition of

 

MPM BioVentures II, LP

     0   

MPM BioVentures II-QP, L.P.

     0   

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

     0   

MPM Asset Management Investors 2002 BVII LLC

     0   

MPM Asset Management II, L.P.

     1,356,339 (1) 

MPM Asset Management II LLC

     1,356,339 (1) 

Ansbert Gadicke

     1,372,118 (2) 

Luke B. Evnin

     1,372,118 (2) 

Nicholas Galakatos

     1,372,118 (2) 

Michael Steinmetz

     1,372,118 (2) 

Kurt Wheeler

     1,372,118 (2) 

 

(1) The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG.
(2) The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

 

Page 15 of 20


Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

 

Item 8. Identification and Classification of Members of the Group

Not Applicable

 

Item 9. Notice of Dissolution of a Group

Not Applicable

 

Item 10. Certification

Not Applicable

 

Page 16 of 20


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 11, 2014

 

MPM BIOVENTURES II, L.P.     MPM BIOVENTURES II-QP, L.P.
By:   MPM Asset Management II, L.P.,     By:   MPM Asset Management II, L.P.,
  its General Partner       its General Partner
By:   MPM Asset Management II LLC,     By:   MPM Asset Management II LLC,
  its General Partner       its General Partner
By:  

        /s/ Luke B. Evnin

    By:  

        /s/ Luke B. Evnin

  Name: Luke B. Evnin       Name: Luke B. Evnin
  Title: Investment Manager       Title: Investment Manager
MPM BIOVENTURES GMBH & CO. PARALLEL- BETEILIGUNGS KG     MPM ASSET MANAGEMENT INVESTORS 2002 BVII LLC
By:   MPM Asset Management II LP, in its capacity as the     By:  

        /s/ Luke B. Evnin

Special Limited Partner   Name: Luke B. Evnin
        Title: Investment Manager
By:   MPM Asset Management II LLC, its General Partner      
By:  

        /s/ Luke B. Evnin

     
  Name: Luke B. Evnin      
  Title: Investment Manager      
MPM ASSET MANAGEMENT II L.P.     MPM ASSET MANAGEMENT II LLC
By:   MPM Asset Management II LLC, its General Partner      
By:  

        /s/ Luke B. Evnin

    By:  

        /s/ Luke B. Evnin

  Name: Luke B. Evnin       Name: Luke B. Evnin
  Title: Investment Manager       Title: Investment Manager

 

Page 17 of 20


        /s/ Ansbert Gadicke

        Ansbert Gadicke

   

        /s/ Luke B. Evnin

        Luke B. Evnin

        /s/ Nicholas Galakatos

        Nicholas Galakatos

   

        /s/ Michael Steinmetz

        Michael Steinmetz

        /s/ Kurt Wheeler

        Kurt Wheeler

   

EXHIBITS

 

A: Joint Filing Agreement

 

Page 18 of 20